| The Natural Medicine Division (NMD or Division) is announcing the initiation of rulemaking for HB26-1325, as well as the adoption of emergency rules for the new limited natural medicine sales license.
Upcoming Rulemaking and Stakeholder Engagement
The Division is initiating the rulemaking process to implement recent legislative changes under HB26-1325 and clarify current NMD Rules (1 CCR 213-1). We invite you to participate in our upcoming virtual stakeholder meeting and submit your feedback.
Interested parties can access the initial proposed rule redlines here and may submit written comments using the Division’s written comment form.
Upcoming Events
Virtual Stakeholder Meeting
Date and Time: Wednesday, September 30, 2026, at 1 p.m.
Registration Required: Register here to attend and participate
Final Rulemaking Hearing
Date and Time: Wednesday, November 4, 2026, at 9:30 a.m.
In-Person Attendance: Natural Medicine Division, 1707 Cole Boulevard in Lakewood, Suite 300, Red Rocks Conference Room
Registration Required – Virtual Attendance: Registration details will be included in the agenda and published on the Division’s Rulemaking webpage.
Deadline for all Written Comments
Wednesday, November 4, 2026, by 5 p.m.
Key Topics Under Consideration
The State Licensing Authority (SLA) is considering rule revisions to 1 CCR 213-1, including:
- Implementation of HB26-1325, including:
- Temporary Premises Permits
- Limited Sales Licenses
- Process for waiver or adjustment of testing requirements
- Clarifying application requirements
- Updating inventory tracking and Administration Session reporting frequencies
Note: These are some of the proposed topics. The SLA may consider additional rules or revisions necessary to interpret and implement the Natural Medicine Code. |